(Q50521476)

14 March 2018

title

IgG N-glycans as potential biomarkers for determining galactose tolerance in Classical Galactosaemia (English)

1 reference

14 March 2018

1 reference

K P Coss

1

1 reference

14 March 2018

J C Byrne

2

1 reference

14 March 2018

D J Coman

3

1 reference

14 March 2018

B Adamczyk

4

1 reference

14 March 2018

J L Abrahams

5

1 reference

14 March 2018

R Saldova

6

1 reference

14 March 2018

A Y Brown

7

1 reference

14 March 2018

O Walsh

8

1 reference

14 March 2018

U Hendroff

9

1 reference

14 March 2018

C Carolan

10

1 reference

14 March 2018

P M Rudd

11

1 reference

14 March 2018

E P Treacy

12

1 reference

14 March 2018

publication date

7 November 2011

1 reference

14 March 2018

Molecular Genetics and Metabolism

published in

1 reference

14 March 2018

volume

105

1 reference

14 March 2018

issue

2

1 reference

14 March 2018

page(s)

212-220

1 reference

14 March 2018

Long‐term prognosis in galactosaemia: Results of a survey of 350 cases

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.10.018

Cognitive functioning, neurologic status and brain imaging in classical galactosemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.10.018

Galactosaemia: relationship of IQ to biochemical control and genotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.10.018

The relationship of genotype to cognitive outcome in galactosaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.10.018

Verbal dyspraxia in children with galactosemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.10.018

Long-term outcome in 134 patients with galactosaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.10.018

Effects of galactosemia in utero

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.10.018

Classical galactosaemia revisited.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.10.018

Neurologic complications in galactosemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.10.018

7 January 2021

Clouds over galactosemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.10.018

A woman with untreated galactosaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.10.018

Untreated classical galactosemia patient with mild phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.10.018

Galactosemia, a single gene disorder with epigenetic consequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.10.018

High tolerance for oral galactose in classical galactosaemia: dietary implications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.10.018

Age dependence of endogenous galactose formation in Q188R homozygous galactosemic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.10.018

Endogenous synthesis of galactose in normal men and patients with hereditary galactosaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.10.018

The rate of de novo galactose synthesis in patients with galactose-1-phosphate uridyltransferase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.10.018

Pathways of galactose metabolism by galactosemics: evidence for galactose conversion to hepatic UDPglucose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.10.018

Early diagnosis of inherited metabolic disorders towards improving outcome: the controversial issue of galactosaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.10.018

Outcomes of siblings with classical galactosemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.10.018

Biochemical monitoring of treatment for galactosaemia: biological variability in metabolite concentrations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.10.018

On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.10.018

IgG glycosylation analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.10.018

A modified method for the estimation of galactose-1-phosphate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.10.018

Gas chromatographic measurement of blood and urine glucose and other monosaccharides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.10.018

Genetic basis of transferase-deficient galactosaemia in Ireland and the population history of the Irish Travellers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.10.018

HPLC-based analysis of serum N-glycans on a 96-well plate platform with dedicated database software.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.10.018

Nonselective and efficient fluorescent labeling of glycans using 2-amino benzamide and anthranilic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.10.018

Sequencing of N-linked oligosaccharides directly from protein gels: in-gel deglycosylation followed by matrix-assisted laser desorption/ionization mass spectrometry and normal-phase high-performance liquid chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.10.018

High throughput isolation and glycosylation analysis of IgG-variability and heritability of the IgG glycome in three isolated human populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.10.018

Site-specific glycosylation of human immunoglobulin G is altered in four rheumatoid arthritis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.10.018

Glycan characterization of PSA 2-DE subforms from serum and seminal plasma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.10.018

Defective galactosylation of serum transferrin in galactosemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.10.018

Detailed glycan analysis of serum glycoproteins of patients with congenital disorders of glycosylation indicates the specific defective glycan processing step and provides an insight into pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.10.018

Screening for congenital disorders of glycosylation (CDG): transferrin HPLC versus isoelectric focusing (IEF).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.10.018

Carbohydrate-deficient transferrin in galactosaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.10.018

Altered follicle stimulating hormone isoforms in female galactosaemia patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.10.018

Serum lysosomal enzyme abnormalities in galactosaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.10.018

Involvement of endoplasmic reticulum stress in a novel Classic Galactosemia model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.10.018

Hypoglycosylation with increased fucosylation and branching of serum transferrin N-glycans in untreated galactosemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.10.018

Structural changes of immunoglobulin G oligosaccharides with age in healthy human serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.10.018

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.10.018

Mini review: immune response to myelin-derived sulfatide and CNS-demyelination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.10.018

White matter in learning, cognition and psychiatric disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.10.018

10.1016/J.YMGME.2011.10.018

7 January 2021

Identifiers

DOI

1 reference

14 March 2018

release_zzv5h66jircvncugeb6e2crhae

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zzv5h66jircvncugeb6e2crhae

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

14 March 2018